Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an average 12% body weight loss in a Phase 3 trial. The study, involving overweight or obese adults, revealed significant weight reduction and improved cardiovascular markers.
from Times of India https://ift.tt/9oYjVrR
https://ift.tt/hjHtTCz Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an average 12% body weight loss in a Phase 3 trial. The study, involving overweight or obese adults, revealed significant weight reduction and improved cardiovascular markers.
Home
/
Breaking News
/
Eli Lilly’s daily GLP-1 pill shows strong weight loss results without food restrictions
Subscribe to:
Post Comments
(
Atom
)
0 Comments :
Post a Comment
Please do not post the SPAM comment.